SequelSEC

CapForce Inc. CFOR

Services-Medical Laboratories · CIK 0001293818 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$76.20M
Fiscal year ended 2026-06-30
Operating income
$64.63M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$11.60MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.95Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income0.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Medical Laboratories filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue0.2%0th
Net margin78.2%100th
Operating margin79.6%100th
R&D / revenue0.0%0th
Revenue YoY growth481.2%100th
Current ratio0.22x8th
SBC / revenue1.1%10th
Effective tax rate3.3%25th
FCF margin-4.1%59th

CapForce Inc. (CFOR) reported revenue of $76.20M and net income of $62.28M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CapForce Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

CapForce Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$76.20M
Cost of revenueUnavailable
Gross profitUnavailable
Operating income$64.63M
Net income$62.28M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$65.00M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$3.54M
General & administrative$3.54M
Selling & marketing$5.68K

Balance

CapForce Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$143.78K
Total assets$87.68M
Current assets$50.71M
Total liabilities$13.40M
Current liabilities$11.87M
Total equity incl. NCI$74.28M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$50.26M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$3.16M

Cash flow

CapForce Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$1.52M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$931.45K
Net change in cash-$682.42K
Stock-based compensation$339.68K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$200.46K

Derived

CapForce Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin84.8%
FCF marginUnavailable
SBC / revenue0.4%
Current ratio4.27x
Revenue YoY growth746.7%
Net margin81.7%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CFOR in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-06-12View SEC filing
10-K · Filed 2026-05-26View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-10-01View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CDNA CELC CSTL DGX FCHS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.